Jellatech

Jellatech is a B2B biotech business based in Raleigh, NC producing human proteins for advancements in health using our unique cell-based technology. By unlocking the production of complex proteins at scale, Jellatech is enabling the creation of new possibilities for health and longevity, starting with Type I collagen. Jellatech’s mission is to revolutionize biomedical applications through cutting-edge, human-identical proteins. Jellatech enables advancements in tissue regeneration, injectable aesthetics, cell and gene therapy, and various therapeutic applications by supplying human-identical collagen and complex proteins. With all of it's known limitations, the tissue-extracted bovine and porcine medical grade collagen market for biomedical applications is expected to surpass $2.4B by 2032; however, with the introduction of a viable supply of human collagen across key verticals, the total addressable market (TAM) for human collagen alone could surpass $100-150 billion in the near future. Why Jellatech? Jellatech's platform is the only solution to deliver a reliable, consistent supply of bio-identical, fully functional human type I collagen for biomedical applications. Contact us to learn more. This is just the beginning. The potential is vast, and we’re here to help companies achieve breakthroughs in healthcare and beyond. Join us in unlocking a brighter future.